Inclusion criteria | |
 1. Use of qualitative methods for data collection including focus group discussions or in-depth interviews | |
 2. Focus on the use of complementary medicine products as defined operationally above | |
 3. Described CMP use in pregnancy and/or lactation | |
 4. CMPs were used by the woman for the benefit of her own health in pregnancy, the pregnancy itself, the baby and/or the breastfeeding process | |
 5. Information sources the woman accessed with regards to the CMPs used are reported | |
 6. Health literacy, or related concepts, were discussed | |
Exclusion criteria | |
 • Pre-conceptual folic acid supplementation only | |
 • Trials of CMPs in pregnancy or lactation (trial would have been the information source on the CMP studied) | |
 • Information sources not clearly identifiable | |
 • Potential information sources identified by the authors, but not clearly identified by participants | |
 • Data not collected from pregnant and breastfeeding women themselves | |
 • Data only collected from health care practitioners | |
 • Study protocols or social marketing campaigns | |
 • Overview or commentary papers on CAM modalities, philosophies or practices regarding women’s health | |
 • Overview or commentary papers on biomedical maternity care philosophies | |
 • Commentary papers on CMP use or the lack of uptake of recommended nutritional supplements in pregnancy, including iron, folic acid and iodine. | |
 • Studies where CMPs were given directly to infants, and not the breastfeeding mothers | |
 • Studies focussing on CAM use to treat infertility |